Gilead Sciences | Créances Commerciales

Prix De L'Action
151.44
Variation Quotidienne
0.32 0.21%
Mensuellement
17.30%
Annuel
37.74%
Q1 Prévisions
150.18




Créances Commerciales Changement Date
AbbVie USD 12.77B 132M 2025-09
Agios Pharmaceuticals USD 10.58M 5.55M 2025-12
ALKERMES USD 355.11M 1.22M 2025-09
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amgen USD 9.57B 1.08B 2025-12
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 790.27M 65.59M 2025-09
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Coherus Biosciences USD 62.44M 59.9M 2025-03
Eli Lilly USD 19.46B 2.25B 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Glaxosmithkline GBP 11.16B 3.46B 2025-09
Incyte USD 1.02B 128.52M 2025-12
J&J USD 17.61B 235M 2025-09
Merck USD 12.12B 596M 2025-09
Moderna USD 184M 862M 2025-12
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Novartis USD 8.98B 192M 2025-09
Pfizer USD 18.12B 2.02B 2025-09
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 397M 100M 2025-12
Sarepta Therapeutics USD 395.74M 213.86M 2025-09
United Therapeutics USD 297.7M 81.6M 2025-09
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12


Gilead Sciences Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.